- Source type
- Study
- Access type
- Publisher
- Publisher
- JAMA
- Date
- 2020
- Added
- 2026-06-30
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
88
Peer-reviewed research publisher
- Publisher type
- Peer-reviewed journal
- Bias profile
- Moderate
This source is strongest for clinical outcomes and mechanism and weaker for regulatory status and trial discovery.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 65/100
- Context Source
- Clinical outcomes
- 92/100
- Primary Anchor
- Mechanism
- 90/100
- Primary Anchor
- Safety
- 86/100
- Strong Support
- Consumer context
- 72/100
- Context Source
- Trial discovery
- 65/100
- Context Source
Best used for
- Primary studies
- Systematic reviews
- Mechanistic research
Weak for
- Regulatory status
- Universal consumer recommendations
Used in Viral Vitalism
Sunscreen: Skin-Cancer Shield or Hormone-Disrupting Trap?
Roles: Primary source
Show section-level references
Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients
Roles: Primary source
Show section-level references
Claim ledger
Claims supported
Reviewed claim cards that cite this source in the evidence graph.
sunscreen: Several sunscreen active ingredients can enter the bloodstream under
Several sunscreen active ingredients can enter the bloodstream under maximal-use conditions, but the clinical significance remains under study.
sunscreen: Some chemical sunscreen filters need more safety data and
Some chemical sunscreen filters need more safety data and can be systemically absorbed, but absorption alone does not prove clinical endocrine harm.
Related studies
Related sources
FDA Q&A: Proposed order for over-the-counter sunscreen
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 9 connections
AABB: FDA warns against use of unapproved HCT/Ps
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 91
- Publisher
- AABB
- Access
- Publisher
- Usage
- 1 connection
FDA: 2026 Safety and Availability Communications
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 94
- Publisher
- FDA
- Access
- Official
- Usage
- 1 connection
FDA: Patient and consumer warning about unapproved human cell and tissue products
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 94
- Publisher
- FDA
- Access
- Official
- Usage
- 1 connection
FDA's concerns with unapproved GLP-1 drugs used for weight loss
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 4 connections
Washington Post: How to pick a sunscreen
The Washington Post used across the Viral Vitalism evidence library.
- Trust score
- 60
- Publisher
- The Washington Post
- Access
- Publisher
- Usage
- 5 connections